News & Events about 89bio Inc.
Globe Newswire
2 months ago
- New analysis of cohort 7 data using a three-reader pathologist panel showed that 6/19 patients scored as having fibrosis stage 4 at baseline (putative F4); excluding these patients resulted in higher histological response rates in the patients with F2-F3 fibrosis than previously reported - SAN ...
Thinking about buying stock in Purecycle Technologies, Sellas Life Sciences, Nurix Therapeutics, Pineapple Energy, or 89bio? Thinking about buying stock in Purecycle Technologies, Sellas Life Sciences, Nurix Therapeutics, Pineapple Energy, or 89bio? PR Newswire NEW YORK, Oct. 21, 2022 NEW YORK...
Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies? Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies? PR Newswire NEW YORK, Sept. 14, 2022 NEW...
Thinking about buying stock in Akero Therapeutics, Planet Labs, Kaspien Holdings, Neurobo Pharmaceuticals, or 89Bio? Thinking about buying stock in Akero Therapeutics, Planet Labs, Kaspien Holdings, Neurobo Pharmaceuticals, or 89Bio? PR Newswire NEW YORK, Sept. 13, 2022 NEW YORK, Sept. 13, 2022...
Globe Newswire
5 months ago
-Results featured in a late-breaking oral presentation- -Treatment with pegozafermin demonstrated consistent and significant benefit in triglyceride (TG) reduction as well as improvements in liver fat and glycemic control- -Positive data support the advancement into a Phase 3 trial in SHTG- SAN ...